Fresh Tracks Therapeutics Competitors and Similar CompaniesClear all

Fresh Tracks Therapeutics's competitors and similar companies include Pharming Group, Alexion Pharmaceuticals, Macopharma and PlasmaGen Biosciences.

	Fresh Tracks Therapeutics Fresh Tracks Therapeutics (formerly known as Brickell Biotech) is a clinical-stage pharmaceutical company focused on the development of innovative and differentiated therapeutics for the treatment of skin diseases.	Pharming Group Pharming Group is a biopharmaceutical company developing protein replacement therapies and precision medicines for the treatment of rare diseases.	Alexion Pharmaceuticals Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases.	Macopharma Macopharma is a provider of blood transfusion and bio-sourced therapies.	PlasmaGen Biosciences PlasmaGen BioSciences is a bio-pharmaceutical organization specializing in plasma protein therapy.
Founding Date	Founding Date 2009	Founding Date 1988	Founding Date 1992	Founding Date 1977	Founding Date 2010
Type	Type Public	Type Public	Type Public	Type Private	Type Private
Tags	Tags Healthcare biotech pharma therapy	Tags Healthcare biotech pharma therapy	Tags Healthcare biotech pharma therapy	Tags Healthcare biotech pharma therapy	Tags Healthcare biotech pharma therapy
Locations	Locations Boulder, US HQ Carmel, US	Locations Leiden, NL HQ Leiden, NL	Locations Boston, US HQ Frenchs Forest, AU Wien, AT Elsene, BE São Paulo, BR Vaughan, CA Shanghai, CN see more	Locations Tourcoing, FR HQ Mouvaux, FR	Locations Bengaluru, IN HQ Bengaluru, IN
Employees	Employees 1338% decrease	Employees 404	Employees 10,6006% increase	Employees 901	Employees 4032% increase
Valuation ($)	Valuation ($) 4.3 m	Valuation ($) 590.3 m	Valuation ($) 40.3 b	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $8m (FY, 2023)	Revenue (est.) $376.1m (FY, 2025)	Revenue (est.) $6.1b (FY, 2020)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $41.6m (FY, 2025)	Cost of goods $553.5m (FY, 2020)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $341m (FY, 2025)	Gross profit $5.5b (FY, 2020)	Gross profit N/A	Gross profit N/A
Net income	Net income ($5.7m) (FY, 2023)	Net income $2.5m (FY, 2025)	Net income $603.4m (FY, 2020)	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised $ 25.4m	Total funding raised N/A	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 25m